Office of Research & Development |
![]() ![]() |
Project Number: | I01CX001261-01A1 |
Title: | Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults |
Principal Investigator: | Cynthia M Carlsson |
Location: | Madison, WI |
Congressional District Code: | 2 |
Research Service: | Clinical Science R&D |
Project Period: | July 2016 - June 2022 |
FY 2021 Funding Amount: | $123,750 |
Total Award Amount (all years): |
$858,686 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: DESCRIPTION (provided by applicant): Over five million Americans have Alzheimer's disease (AD), and this number is expected to triple by 2050 unless effective preventive strategies are identified. Veterans are at an even higher risk for AD than the general population, possibly due to their increased exposure to factors that accelerate AD pathology, including vascular risk factors, traumatic brain injury, and post-traumatic stress disorder. AD pathology occurs decades before cognitive... |